Ads
related to: mild diffuse hepatic fatty infiltration of liver- Management Information
Discover More Information
On The Patient Site.
- Downloadable Resources
Download Doctor Discussion Guide
And Other Helpful Patient Resources
- Tools And Support
Get Helpful Resources And
Support For Patients.
- Specialist Finder
Search for providers specializing
in management options.
- Patient Ambassador
Register for an event & learn more
from a Nurse Educator.
- Stay Informed
Sign Up For Updates
And Get Helpful Information.
- Management Information
Search results
Results From The WOW.Com Content Network
Fatty liver disease (FLD), also known as hepatic steatosis and steatotic liver disease (SLD), is a condition where excess fat builds up in the liver. [1] Often there are no or few symptoms. [ 1 ] [ 2 ] Occasionally there may be tiredness or pain in the upper right side of the abdomen . [ 1 ]
Steatohepatitis is a type of fatty liver disease, characterized by inflammation of the liver with concurrent fat accumulation in liver. Mere deposition of fat in the liver is termed steatosis, and together these constitute fatty liver changes. [1] There are 2 main types of fatty liver disease (FLD):
No single mechanism leading to steatosis exists; rather, a varied multitude of pathologies disrupt normal lipid movement through the cell and cause accumulation. [7] These mechanisms can be separated based on whether they ultimately cause an oversupply of lipid which can not be removed quickly enough (i.e., too much in), or whether they cause a failure in lipid breakdown (i.e., not enough used).
Focal fatty liver (FFL) is localised or patchy process of lipid accumulation in the liver. [1] It is likely to have different pathogenesis than non-alcoholic steatohepatitis which is a diffuse process. FFL may result from altered venous flow to liver, tissue hypoxia and malabsorption of lipoproteins.
Metabolic dysfunction–associated steatotic liver disease (MASLD), previously known as non-alcoholic fatty liver disease (NAFLD), [a] is a type of chronic liver disease. This condition is diagnosed when there is excessive fat build-up in the liver ( hepatic steatosis ), and at least one metabolic risk factor.
In the axial plane, the caudate lobe should normally have a cross-section of less than 0.55 of the rest of the liver. [2] Other ultrasound studies have suggested hepatomegaly as being defined as a longitudinal axis > 15.5 cm at the hepatic midline, or > 16.0 cm at the midclavicular line. [17] [18]
Ads
related to: mild diffuse hepatic fatty infiltration of liver